Stock CELZ CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Creative Medical Technology Holdings, Inc.

Equities

CELZ

US22529Y4089

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-30 pm EDT 		5-day change 1st Jan Change
4.44 USD +1.25% Intraday chart for Creative Medical Technology Holdings, Inc. -7.89% -3.69%
Mar. 22 Tranche Update on Creative Medical Technology Holdings, Inc.'s Equity Buyback Plan announced on June 12, 2023. CI
Mar. 22 Creative Medical Technology Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.

Number of employees: 4

Sales per Business

USD in Million2022Weight2023Weight Delta
Stem Cell Treatments
100.0 %
0 100.0 % 0 100.0 % -89.84%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
0 100.0 % 0 100.0 % -89.84%

Managers

Managers TitleAgeSince
Timothy Warbington CEO
 Chief Executive Officer 63 16-05-17
Donald Dickerson DFI
 Director of Finance/CFO 59 16-01-31
Courtney Bartlett CTO
 Chief Tech/Sci/R&D Officer - -
Sahil Nock PRN
 Corporate Officer/Principal - 22-02-27

Members of the board

Members of the board TitleAgeSince
Susan Snow BRD
 Director/Board Member 67 21-12-01
Donald Dickerson DFI
 Director of Finance/CFO 59 16-01-31
Timothy Warbington CEO
 Chief Executive Officer 63 16-05-17
Michael H. Finger BRD
 Director/Board Member 77 21-12-01
Bruce S. Urdang BRD
 Director/Board Member 66 21-12-01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,414,126 1,319,869 ( 93.33 %) 57,500 ( 4.066 %) 93.33 %

Shareholders

NameEquities%Valuation
Creative Medical Health, Inc.
1.673 %
22,695 1.673 % 118 241 $
Vanguard Group, Inc. (Subfiler)
1.299 %
17,629 1.299 % 91 847 $
Aaron Wealth Advisors LLC
1.209 %
16,400 1.209 % 85 444 $
Timothy Warbington
0.9000 %
12,209 0.9000 % 63 609 $
Michael H. Finger
0.1364 %
1,850 0.1364 % 9 639 $
UBS Securities LLC
0.0768 %
1,042 0.0768 % 5 429 $
Tower Research Capital LLC
0.0666 %
903 0.0666 % 4 705 $
Morgan Stanley Smith Barney LLC
0.001474 %
20 0.001474 % 104 $
Wells Fargo Bank NA
0.000811 %
11 0.000811 % 57 $
IFP Advisors, Inc.
0.000369 %
5 0.000369 % 26 $
NameEquities%Valuation
Timothy Warbington
100.00 %
3,000,000 100.00 % 42 000 $

Company contact information

Creative Medical Technology Holdings, Inc.

211 East Osborn Road

85012, Phoenix

+

http://www.creativemedicaltechnology.com
address Creative Medical Technology Holdings, Inc.(CELZ)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
4.44 USD
Average target price
30 USD
Spread / Average Target
+575.68%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Stock Creative Medical Technology Holdings, Inc.
-3.69% 5.95M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-3.46% 102B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+1.41% 96.29B
ARGENX SE Stock argenx SE
+2.13% 22.18B
BIONTECH SE Stock BioNTech SE
-15.84% 21.2B
GENMAB A/S Stock Genmab A/S
-9.21% 18.31B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.98% 17.38B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.65% 16.36B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+4.39% 13.97B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+31.35% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. CELZ Stock
  4. Company Creative Medical Technology Holdings, Inc.